Moreover, the research by A. Rezania et al. [26] established that the insulin-secreting cells derived from human embryonic stem cells could be an effective alternative to the pancreatic progenitors or cadaveric islets that have been considered for the treatment of DM. This evidence concerns the gene INS and diabetes mellitus.